
- Severe Hematoma Expansion Worsens Outcome in Smaller Intracerebral Hemorrhages
- Do Patients With Multiple Sclerosis Face Worse COVID-19 Outcomes?
- Physical Jobs Tied to Higher Risk for Later Cognitive Impairment
- Machine Algorithm IDs Unruptured Cerebral Aneurysms That Get Missed
- Cannabis Reduces T-Cell Activation, Exhaustion, and Senescence in Patients With HIV
- Intraoperative Sufentanil Increases Postoperative Nausea and/or Vomiting Risk
- FDA to Review New Formulation of Ingrezza for Tardive Dyskinesia, Huntington Disease Chorea
- Severe Outcomes in COVID-19 More Likely With Influenza Coinfection
- Vaccines Not Associated With MS Flare-Ups That Require Hospitalization
- Are Female Gender, Anti-AChR Positivity Key Risk Factors for Generalized MG?
- Higher Consumption of Ultraprocessed Foods May Increase Risk for Later Depression
- Midlife Insomnia May Increase Risk for Later Dementia
Clinical Tools
Powered by
Recommendations Developed for Acetaminophen Poisoning
Does Continuing 5-ASA During Vedolizumab Treatment Improve IBD Clinical Outcomes?
Psychotherapy Improves Mental Health But Not IBD Disease Activity
FDA Grants Accelerated Approval to Elrexfio for Relapsed/Refractory Multiple Myeloma
Dupilumab Treatment Beneficial for Sleep in Atopic Dermatitis